Cas 676479-17-7,(S)-2,2,2-trifluoro-N-{1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl}-acetamide

676479-17-7

Post Buying Request

Basic information

Product Name: (S)-2,2,2-trifluoro-N-{1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl}-acetamide
Synonyms: (S)-2,2,2-trifluoro-N-{1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl}-acetamide
CAS NO:676479-17-7
Molecular Formula:
Molecular Weight: 396.341
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-2,2,2-trifluoro-N-{1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl}-acetamide(CAS DataBase Reference)
NIST Chemistry Reference: (S)-2,2,2-trifluoro-N-{1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl}-acetamide(676479-17-7)
EPA Substance Registry System: (S)-2,2,2-trifluoro-N-{1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl}-acetamide(676479-17-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 676479-17-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

676479-17-7 Suppliers

Recommended suppliers

676479-17-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 676479-17-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,4,7 and 9 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 676479-17:
(8*6)+(7*7)+(6*6)+(5*4)+(4*7)+(3*9)+(2*1)+(1*7)=217
217 % 10 = 7
So 676479-17-7 is a valid CAS Registry Number.

676479-17-7Upstream product

676479-17-7Downstream Products

676479-17-7Relevant academic research and scientific papers

PYRROLIDONE DERIVATIVES AS MAOB INHIBITORS

-

Page 22, (2010/11/30)

Racemic or enantiomerically pure 4-pyrrolidino derivatives of the formula (I), processes for their preparation, pharmaceutical compositions comprising said derivatives, and their use in the prevention and treatment of a disease which is mediated by a mono

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 676479-17-7